ArticleAdvances in rheumatology (London, England)2026
Advances and barriers in gender equity within Brazilian rheumatology: a two-year follow-up study.
Article in Advances in rheumatology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionGender equity is increasingly recognized as essential to integrity and sustainability of the medical workforce, yet significant disparities remain. This study aims to evaluate longitudinal trends in gender equity within Brazilian rheumatology, focusing on career advancement, work-family interface, and workplace safety.
methodsThis comparative cross-sectional study analyzed two self-administered, web-based surveys conducted at different moments among members of the Brazilian Society of Rheumatology (SBR), to assess temporal changes. The surveys included Reuma Equity (2022, n = 459, 67.1% women) and the Brazilian subset of the global Coalition for Health and Gender Equity (CHANGE) (2024, n = 301, 74.4% women). Statistical analyses included Pearson's chi-square, Fisher's exact, and Mann-Whitney tests, with a significance level set at p ≤ 0.05.
resultsIn both moments, female rheumatologists were younger [2022: OR 3.7, (95% CI 2.2-6.4, p = 0.001); 2024: OR 4.3, (95% CI 2.2-8.6, p < 0.001)], carried a greater burden of domestic labor [2022: OR 2.8, (95% CI 1.8-4.3, p < 0.001); 2024: OR 2.8, (95% CI 1.5-5.1, p < 0.001)], and men were more likely to occupy prominent positions at national congresses [2022: OR 2.3, (95% CI 1.5-3.4, p < 0.001); 2024: OR 2.1, (95%CI 1.3-3.6, p = 0.005)]. There was an increase in the probability of women being more likely to refuse career progression for family-related reasons [2022: OR 2.1, (95% CI 1.2-3.7, p = 0.038); 2024: OR 3.2, (95% CI 1.8-6.1, p < 0.001)], and a decrease in reported rates of sexual harassment [2022: OR 4.2, (95% CI 2.5-6.9, p < 0.001); 2024: OR 2.6, (95% CI 1.4-4.6, p = 0.002)]. Gender disparities in medical visit fees (lower fees: 69.2% women and 57.6% men, p = 0.043), and medical visit duration (longer appointments: 78.2% women and 69.5% men, p = 0.014) observed in 2022 disappeared by 2024 (p = 1.00, p = 0.318).
conclusionAlthough representation in Brazilian rheumatology is increasing, women continue to shoulder disproportionate domestic responsibilities, decline career opportunities more often, and experience higher rates of harassment. Even so, improvements were observed in professional indicators and in the male' views, suggesting gradual progress toward gender equity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.